TRIAL DETAIL
Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor |
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor |
|||
Status: |
Completed |
|||
Phase: |
2 |
Start Date 02/01/2005 |
Age of Trial (yrs) 19.8 |
|
Treatment Phase: |
Neoadjuvant |
|||
Drug Category: |
KIT/PDGFRA inhibitor |
|||
Strategy: |
Block KIT |
|||
Trial Type: |
Specifically GIST and only GIST |
|||
Other Protocol IDs: |
CDR0000430499
KRDI-TUM-GIST-SCTI571-BDE43
EU-20507 |
|||
Sponsor: |
Technische Universitat Munchen |
|||
Patient Contact: |
||||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Oral |
|||
Trial Notes: |
This is a neoadjuvant trial of imatinib (Glivec). |
|||
Trial Links |
Trial Results |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
Vienna |
A1090 |
Austria |
|||
Weisbaden |
D-65199 |
Germany |
|||
Munich |
D-81675 |
Germany |
|||
Hamburg |
D-20246 |
Germany |
|||
Lindenberger Weg 80 |
Berlin |
D-13125 |
Germany |
||
Tuebingen |
D-72076 |
Germany |
|||
Bonn |
D-53105 |
Germany |
|||
Cologne |
D-50924 |
Germany |
|||
Munich |
D-81377 |
Germany |